Testing the Combination of the Anti-cancer Drugs XL184 (Cabozantinib) and Nivolumab in Patients With Advanced Cancer and HIV
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Aveni Foundation
ViroMissile, Inc.
Dana-Farber Cancer Institute
AstraZeneca
Washington University School of Medicine
University of Florida
Essen Biotech
Angiex, Inc.
Alliance for Clinical Trials in Oncology
University of Nebraska
Adela, Inc